RxSight (RXST) Other Non-Current Assets (2020 - 2026)
RxSight (RXST) posted Other Non-Current Assets of $1.0 million for Q1 2026, up 36.8% on a QoQ basis from $750000.0 in Q4 2025, and up 36.8% year-over-year from $750000.0 in Q1 2025.
RxSight (RXST) Other Non-Current Assets (2020 - 2026) Analysis & Trends
RxSight's Other Non-Current Assets history runs 7 years deep, the most recent figure standing at $1.0 million for Q1 2026.
- Quarterly Other Non-Current Assets rose 36.8% year-over-year to $1.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.0 million (up 36.8% YoY) and the FY2025 annual result came in at $750000.0, up 108.33% from the prior year.
- Other Non-Current Assets was $1.0 million for Q1 2026 at RxSight, up from $750000.0 in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $1.0 million in Q1 2026 and bottomed at $188000.0 in Q2 2022.
- A 5-year average of $613764.7 and a median of $711000.0 in 2023 frame the typical range for Other Non-Current Assets.
- Annual changes were most pronounced in 2022 — Other Non-Current Assets tumbled 86.01% — and 2025, when it soared 251.17%.
- RxSight's Other Non-Current Assets stood at $767000.0 in 2022, then slipped by 7.3% to $711000.0 in 2023, then tumbled by 49.37% to $360000.0 in 2024, then soared by 108.33% to $750000.0 in 2025, then soared by 36.8% to $1.0 million in 2026.
- Business Quant data shows RXST's Other Non-Current Assets at $1.0 million in Q1 2026, $750000.0 in Q4 2025, and $748000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 3.17 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 4.15 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 2.05 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 738.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 285.90 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 828.89 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 2.25 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 164.00 Mn |
| 10 | RxSight | 221.81 Mn | -196.39 Mn | 23.50 Mn | 1.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.03 Mn |
| Dec 31, 2025 | 750,000.00 |
| Sep 30, 2025 | 748,000.00 |
| Jun 30, 2025 | 542,000.00 |
| Mar 31, 2025 | 750,000.00 |
| Dec 31, 2024 | 360,000.00 |
| Sep 30, 2024 | 213,000.00 |
| Jun 30, 2024 | 711,000.00 |
| Mar 31, 2024 | 226,000.00 |
| Dec 31, 2023 | 711,000.00 |
| Sep 30, 2023 | 711,000.00 |
| Jun 30, 2023 | 348,000.00 |
| Mar 31, 2023 | 761,000.00 |
| Dec 31, 2022 | 767,000.00 |
| Sep 30, 2022 | 811,000.00 |
| Jun 30, 2022 | 188,000.00 |
| Mar 31, 2022 | 811,000.00 |
| Dec 31, 2021 | 811,000.00 |
| Sep 30, 2021 | 287,000.00 |
| Jun 30, 2021 | 1.34 Mn |